Aveo Partners

The healthcare allocation is structured to generate returns through multiple channels: Capital Appreciation Investments in companies that grow revenues, expand margins, successfully commercialize new products, and strengthen competitive positions can deliver long-term price appreciation.

Income Generation Dividend-paying pharmaceutical, medical device, and select healthcare infrastructure companies contribute to a stable income component that supports overall portfolio yield.

Strategic Reinvestment Profits realized from mature or fully valued positions are selectively reinvested into emerging healthcare innovations and undervalued opportunities, reinforcing the compounding effect over time.

Private Market Participation (Where Applicable) Where strategies permit, selective investments in private healthcare businesses may generate enhanced return potential through value creation prior to public listing, strategic sale, or broader market recognition.

Healthcare investments are actively monitored to maintain alignment with strategic objectives, risk parameters, and evolving industry dynamics. Ongoing oversight includes:

• Analysis of revenue, earnings, and cash flow trends
• Assessment of R&D pipelines and product life cycles
• Monitoring of regulatory, pricing, and reimbursement developments
• Evaluation of competitive positioning and market share
• Continuous review of valuations relative to fundamentals and peers

Allocations are adjusted when warranted to optimize exposure, preserve capital, and capture new opportunities—whether by increasing high-conviction positions, reducing exposure where risk has risen, or reallocating capital to more attractive segments.

Healthcare exposure is governed by a structured oversight model designed to enhance resilience while preserving growth participation. This framework applies clear position sizing discipline and concentration limits, diversifies across key healthcare sub-sectors (including pharmaceuticals, biotechnology, medical devices, digital health, and services), and maintains geographic diversification across major developed and select emerging markets. It incorporates ongoing regulatory and policy risk assessment at both country and sub-sector levels, as well as active liquidity management to ensure flexibility under varying market conditions. Collectively, these measures are intended to mitigate idiosyncratic risk, reduce sensitivity to single events, and maintain meaningful exposure to sector-level growth.

The return potential of healthcare is underpinned by enduring global trends that support sustained growth in demand. Aging populations in developed markets, rising middle-class incomes and improved healthcare access in emerging economies, and ongoing technological breakthroughs in pharmaceuticals, biotechnology, and medical devices all contribute to a steadily expanding need for treatments and services. At the same time, the growing focus on chronic disease management and specialty care, together with increasing digitalization and data integration across healthcare systems, is reshaping how care is delivered and managed. Collectively, these structural tailwinds drive persistent demand for healthcare products, services, and infrastructure, supporting long-term earnings growth and capital appreciation across portfolio holdings.